Navigation Links
Honeywell Technology Selected to Control Manufacturing Processes at Major U.S. Biotech Site

Solutions Will Help Drive Production Efficiency and Reliability for New Shire Human Genetic Therapies Facility

PHOENIX, March 12 /PRNewswire-FirstCall/ -- Honeywell (NYSE: HON) today announced it will help a leading specialty biopharmaceutical organization expand its research and development capabilities for creating life-saving medications. Shire Human Genetic Therapies (HGT), a business unit of Shire plc, will use several Honeywell solutions - including Experion(R) Process Knowledge System (PKS), Experion Batch Manager, the OneWireless(TM) industrial wireless network and Uniformance Process Historian Database (PHD) - to control manufacturing processes at its new $250-million production facility in Lexington, Massachusetts.

Shire HGT is committed to developing, manufacturing, and commercializing therapies for life-threatening genetic diseases. The new facility is scheduled for completion in spring 2010 and will be the largest disposable biotechnology site in the United States. This is a new concept where disposable vessels and tank liners are used to reduce the cost of cleaning and verification of process equipment. The site also will include cell-culture production, a clinical suite, and just-in-time warehousing.

"Technology that simplifies scale-up from R&D to commercialized production is critical for biotech facilities to produce as efficiently and reliably as possible," said Don Wuchterl, Director of Manufacturing, Shire Human Genetic Therapies. "Experion and OneWireless are proven to streamline operations and will provide the flexibility required for a multi-purpose facility such as ours."

Shire will use Experion as the primary control platform for the new facility. The system helps operators run production by integrating critical subsystems throughout the plant, providing a single view into the manufacturing process via Experion client operator stations. The processing capacity of the C300 controller will reduce the amount of hardware needed to automate Shire's manufacturing process, as well as reduce operating costs. Shire will also use one of the newest additions to the Experion product line, Experion Batch Manager. Introduced in 2008, Experion Batch Manager further simplifies operations by allowing manufacturers to quickly execute complex batch recipes reliably in a regulated environment.

Additionally, the OneWireless mesh network technology will allow Shire to mount controllers on moveable equipment without having to worry about cabling issues, which can help increase their production flexibility, safety and efficiency. Also, wireless remote operator stations will be used to help reduce the overall number of stations required and eliminate the need for expensive hardened enclosures in environmentally sensitive areas.

Honeywell also will provide its Uniformance Process Historian Database (PHD) technology. Uniformance will pull information from Experion and help improve operations by allowing Shire operators to quickly store, retrieve and analyze process control data. The Honeywell solutions are ideal because they adhere to stringent pharmaceutical industry regulations and will allow Shire to scale the overall process control system as it plans for future expansions.

"Our technology enables lower production costs so biopharmaceutical producers like Shire can reinvest in research and development and deliver products to market faster," said Don Maness, regional general manager for Honeywell Process Solutions. "Additional benefits include lower validation costs, faster project implementation and reduced training requirements, all of which help manufacturers achieve operational readiness from day one and drive improved business performance."

To learn more about Honeywell's Experion PKS, Experion Batch Manager, OneWireless, Uniformance PHD, and other solutions that improve performance, visit

Honeywell International is a $37 billion diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; automotive products; turbochargers; and specialty materials. Based in Morris Township, N.J., Honeywell's shares are traded on the New York, London and Chicago Stock Exchanges. For additional information, please visit Honeywell Process Solutions is part of Honeywell's Automation and Control Solutions group, a global leader in providing product and service solutions that improve efficiency and profitability, support regulatory compliance, and maintain safe, comfortable environments in homes, buildings and industry. For more information about Process Solutions, access

This release contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of fact, that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Forward-looking statements are based on management's assumptions and assessments in light of past experience and trends, current conditions, expected future developments and other relevant factors. They are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by our forward-looking statements. Our forward-looking statements are also subject to risks and uncertainties, which can affect our performance in both the near- and long-term. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.

Experion(R) is a registered trademark and OneWireless(TM) is a trademark of Honeywell International Inc.

SOURCE Honeywell
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Honeywell HomMed Wins 2008 Medical Design Excellence Award for Genesis DM Remote Care Device
2. Frost & Sullivan Commends Honeywell Enraf for Cutting-Edge Products and Post-Sales Support
3. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
4. Novel Technology Breaks Through Cancer Pain
5. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
6. Advanced Cell Technology Announces Proposed Financing
7. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
8. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
9. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
10. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
11. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
Post Your Comments:
(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight ... solutions to the healthcare market. The company's primary focus is on new product ... marketing strategies that are necessary to help companies efficiently bring their products to ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, Biometrics & ... & Other Service  The latest report from ... of the global Border Security market . Visiongain ... billion in 2016. Now: In November 2015 ... and hardware technologies for advanced video surveillance. ...
(Date:5/12/2016)... , May 12, 2016 ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: ... to provide their customers enhanced security to access ...
Breaking Biology News(10 mins):